Home/Filings/4/0001209191-21-040466
4//SEC Filing

DiTolla Michael 4

Accession 0001209191-21-040466

CIK 0000811240other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 9:10 PM ET

Size

8.1 KB

Accession

0001209191-21-040466

Insider Transaction Report

Form 4
Period: 2021-06-11
Transactions
  • Award

    Stock Appreciation Right

    2021-06-11+104,603104,603 total
    Exercise: $0.84Exp: 2031-06-11Common Stock (104,603 underlying)
  • Award

    Restricted Stock Unit

    2021-06-11+110,400110,400 total
    Common Stock (110,400 underlying)
Footnotes (3)
  • [F1]Of the stock appreciation rights subject to this SAR, one-fourth of the stock appreciation rights vest on each of the third, sixth, ninth, and twelfth-month anniversaries of the date of grant.
  • [F2]At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
  • [F3]The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023.

Issuer

BIOLASE, INC

CIK 0000811240

Entity typeother

Related Parties

1
  • filerCIK 0001794696

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 9:10 PM ET
Size
8.1 KB